Ajooni Biotech Limited — Others, 03-02-2025: Shareholders meeting

Ajooni Biotech Limited held its 01st Extra Ordinary General Meeting via video conferencing. Key decisions included an alteration in Clause 7 of the Articles of Association, an increase in authorized share capital, and the issuance of convertible warrants to various stakeholders on a preferential basis. Additionally, Mr. Ishtneet Bhatia was regularized as an Independent Director. These moves suggest a strategic positioning to enhance capital structure and governance, likely aimed at bolstering investor confidence and funding future growth initiatives. Overall, this sets a positive outlook for the company's operational framework and shareholder engagement.